Literature DB >> 10350544

Opioid receptor gene: cytokine response element and the effect of cytokines.

H J Im1, S W Kang, H H Loh.   

Abstract

Previous studies demonstrated that cytokines regulate opioid and opioid receptor gene expression in neuronal and immune cells. The gene sequence analysis of opioid receptors revealed that mu-, delta- and kappa-opioid receptor promoter regions contain potential cytokine response elements (NF-IL6 binding sites). It was postulated that the response elements present in opioid receptor promoter regions may have a role in the cytokine effects on opioid receptor gene expression through cis-trans interaction. The present study investigated whether cytokines have an effect on opioid receptor gene expression by cytokine-induced transcription factor, NF-IL6, using a number of immune cell lines which respond to cytokines. Further investigation was made to determine whether the potential cytokine response element DNA sequences on opioid receptor promoter region have functional significance which may be affected by the DNA context of the opioid receptor promoter in immune cell lines. Tandem repeats of conserved cytokine response elements of IL-6 gene fused to a heteropromoter SV40 were utilized as a positive control and expressed 2-fold increased promoter activity after cytokine stimulation. Transient transfection studies in time courses (24-72 h) and different dose treatments (100-500 U/ml for IL-6 and 50-200 U/ml for IL-1 alpha+beta) were also carried out to investigate the possibility that the upregulated gene expression may be transient or cytokine-dose-dependent. Our data demonstrated that there was no significant cytokine-stimulated opioid receptor gene expression in immune cells tested. In addition, the cytokine response elements (NF-IL6 binding sites) in opioid receptor genes are not functional. These results contradict the previous reports in which cytokines modulated the expression of opioid and opioid receptors in neuronal and immune cells. The possible reasons regarding the different results were discussed. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10350544      PMCID: PMC2900765          DOI: 10.1016/s0006-8993(99)01364-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  20 in total

1.  Characterization of [3H]morphine binding to interleukin-1-activated thymocytes.

Authors:  S Roy; B L Ge; H H Loh; N M Lee
Journal:  J Pharmacol Exp Ther       Date:  1992-11       Impact factor: 4.030

2.  Effect of interleukin-1 on the augmentation of human immunodeficiency virus gene expression.

Authors:  N Kobayashi; Y Hamamoto; Y Koyanagi; I S Chen; N Yamamoto
Journal:  Biochem Biophys Res Commun       Date:  1989-12-15       Impact factor: 3.575

3.  Interleukin 1 and interleukin 2 enhance proopiomelanocortin gene expression in pituitary cells.

Authors:  S L Brown; L R Smith; J E Blalock
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

4.  Regulation of the interleukin-1 beta (IL-1 beta) gene by mycobacterial components and lipopolysaccharide is mediated by two nuclear factor-IL6 motifs.

Authors:  Y Zhang; W N Rom
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

Review 5.  Regulation of expression of the interleukin 6 gene: structure and function of the transcription factor NF-IL6.

Authors:  S Akira; H Isshiki; T Nakajima; S Kinoshita; Y Nishio; S Natsuka; T Kishimoto
Journal:  Ciba Found Symp       Date:  1992

6.  Interleukin-1 beta regulates proenkephalin gene expression in astrocytes cultured from rat cortex.

Authors:  A Negro; A Tavella; L Facci; L Callegaro; S D Skaper
Journal:  Glia       Date:  1992       Impact factor: 7.452

7.  Fos and Jun repress transcription activation by NF-IL6 through association at the basic zipper region.

Authors:  W Hsu; T K Kerppola; P L Chen; T Curran; S Chen-Kiang
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

8.  Recombinant interleukin 6 regulates the transcriptional activation of a set of human acute phase genes.

Authors:  G Morrone; G Ciliberto; S Oliviero; R Arcone; L Dente; J Content; R Cortese
Journal:  J Biol Chem       Date:  1988-09-05       Impact factor: 5.157

9.  Induction of rat acute-phase proteins by interleukin 6 in vivo.

Authors:  T Geiger; T Andus; J Klapproth; T Hirano; T Kishimoto; P C Heinrich
Journal:  Eur J Immunol       Date:  1988-05       Impact factor: 5.532

10.  Constitutive and IL-6-induced nuclear factors that interact with the human C-reactive protein promoter.

Authors:  B Majello; R Arcone; C Toniatti; G Ciliberto
Journal:  EMBO J       Date:  1990-02       Impact factor: 11.598

View more
  4 in total

1.  Sex differences in μ-opioid receptor expression in trigeminal ganglia under a myositis condition in rats.

Authors:  X Zhang; Y Zhang; J Asgar; K Y Niu; J Lee; K S Lee; M Schneider; J Y Ro
Journal:  Eur J Pain       Date:  2013-06-25       Impact factor: 3.931

2.  Dual regulation of mu opioid receptors in SK-N-SH neuroblastoma cells by morphine and interleukin-1β: evidence for opioid-immune crosstalk.

Authors:  Shekher Mohan; Randall L Davis; Udaya DeSilva; Craig W Stevens
Journal:  J Neuroimmunol       Date:  2010-07-07       Impact factor: 3.478

Review 3.  Behavioral and molecular evidence for a feedback interaction between morphine and HIV-1 viral proteins.

Authors:  Sulie L Chang; Kaitlyn P Connaghan
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-15       Impact factor: 4.147

Review 4.  Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.

Authors:  Lawrence Toll; Michael R Bruchas; Girolamo Calo'; Brian M Cox; Nurulain T Zaveri
Journal:  Pharmacol Rev       Date:  2016-03-08       Impact factor: 25.468

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.